InvestorsHub Logo
icon url

biomaven0

04/18/17 5:22 PM

#210699 RE: ghmm #210698

FWIW, the GLGP drug is an order of magnitude less potent than its rivals. Not a red flag, but does raise the possibility of unexpected AEs somewhat.

The INCY rejection does raise the bar here somewhat - the FDA is going to be just as picky on the next candidate.
icon url

Whalatane

04/18/17 6:29 PM

#210701 RE: ghmm #210698

GLGP excellent links ..thx
Dew's board at its best
Kiwi